Kaposi's Sarcoma Associated-Herpes Virus (KSHV) Seroprevalence in Pregnant Women in South Africa by Malope-Kgokong, Babatyi I et al.
RESEARCH ARTICLE Open Access
Kaposi’s Sarcoma Associated-Herpes Virus (KSHV)
Seroprevalence in Pregnant Women in
South Africa
Babatyi I Malope-Kgokong
1,3, Patrick MacPhail
1, Georgina Mbisa
2, Edith Ratshikhopha
3, Mhairi Maskew
1, Lara Stein
3,
Freddy Sitas
4, Denise Whitby
2*
Abstract
Background: Factors previously associated with Kaposi’s sarcoma-associated herpesvirus (KSHV) transmission in
Africa include sexual, familial, and proximity to river water. We measured the seroprevalence of KSHV in relation to
HIV, syphilis, and demographic factors among pregnant women attending public antenatal clinics in the Gauteng
province of South Africa.
Methods: We tested for antibodies to KSHV lytic K8.1 and latent Orf73 antigens in 1740 pregnant women
attending antenatal clinics who contributed blood to the “National HIV and Syphilis Sero-Prevalence Survey - South
Africa, 2001”. Information on HIV and syphilis serology, age, education, residential area, gravidity, and parity was
anonymously linked to evaluate risk factors for KSHV seropositivity. Clinics were grouped by municipality regions
and their proximity to the two main river catchments defined.
Results: KSHV seropositivity (reactive to either lytic K8.1 and latent Orf73) was nearly twice that of HIV (44.6% vs.
23.1%). HIV and syphilis seropositivity was 12.7% and 14.9% in women without KSHV, and 36.1% and 19.9%
respectively in those with KSHV. Women who are KSHV seropositive were 4 times more likely to be HIV positive
than those who were KSHV seronegative (AOR 4.1 95%CI: 3.4 - 5.7). Although, women with HIV infection were
more likely to be syphilis seropositive (AOR 1.8 95%CI: 1.3 - 2.4), no association between KSHV and syphilis
seropositivity was observed. Those with higher levels of education had lower levels of KSHV seropositivity
compared to those with lower education levels. KSHV seropositivity showed a heterogeneous pattern of
prevalence in some localities.
Conclusions: The association between KSHV and HIV seropositivity and a lack of common association with syphilis,
suggests that KSHV transmission may involve geographical and cultural factors other than sexual transmission.
Background
Kaposi Sarcoma-associated herpesvirus (KSHV), also
k n o w na sH u m a nH e r p e s v i r u s8( H H V - 8 )i st h ec a u s a -
tive agent of Kaposi’s sarcoma (KS) [1,2], and is asso-
ciated with primary effusion lymphoma (PEL) [3] and
multicentric Castleman’sd i s e a s e[ 4 ] .P r e v a l e n c eo f
KSHV is elevated in Mediterranean populations [5] and
high in sub-Saharan Africa [6-8]. Unlike in the United
States and Northern Europe, where KSHV is common
mostly in men who have sex with men (MSM), in these
endemic regions KS and KSHV affect the general popu-
lation and it is increasingly apparent that non-sexual
m o d e so ft r a n s m i s s i o np l a yas i g n i f i c a n tr o l ei nt h e
maintenance and spread of KSHV [9,10]
The biological, social and environmental factors
involved in non-sexual horizontal transmission of KSHV
a r es t i l ll a r g e l yu n k n o w n .T h eH I Ve p i d e m i ch a sh a da
profound effect on the rate of KS development in Africa.
In South Africa, HIV co-infection is associated with up
to 50 fold increases in risk for developing KS [11]. The
role of HIV as a risk factor for KSHV infection in South
Africa is unclear; some reports show a strong association
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show a strong association between HIV and KSHV infec-
tion fail to show a similar strong association with other
sexually transmitted infections that are clearly associated
with HIV infection [9,13]. Evidence against sexual trans-
mission of KSHV in heterosexual populations continues
to emerge [12,14-16]. KSHV infection has been asso-
ciated with sources of drinking water and with living in
close proximity to rivers or streams [17,18]. However, the
role of vectors and environmental factors in KSHV ende-
mic countries is a topic of ongoing study [19,20].
HIV seroprevalence in pregnant women attending
public sector antenatal clinics has been used as a reliable
gauge of the South African HIV epidemic [21,22].
Understanding KSHV infection patterns in this group of
women will provide a reasonable and comparable esti-
mate of its impact in the same communities. This study
aims to examine the seroprevalence of KSHV in preg-
nant women attending antenatal clinics and to identify
the risk for KSHV infection in relation to already col-
lected information on socio-demographic and geogra-
phical factors, HIV and syphilis serology.
Materials and methods
Study Patients
This cross sectional study was conducted among 1740
black pregnant women attending public sector antenatal
clinics in Gauteng province, South Africa. Women were
recruited for the study at their first visit to the clinic
during their current pregnancy. The women formed
part of a national HIV and sexually transmitted infec-
tions (STI) study conducted by the National Department
of Health in 2001. A total of 37 clinics within the Gau-
teng Province formed part of this study. Subjects were
then divided into five groups according to the municipa-
lities in which the antenatal clinics were located. These
were: East Rand, Soweto, Pretoria, Vaal Triangle and
West Rand (Figure 1). Gauteng province is the smallest
but second most populated province in South Africa,
occupying a total area of 17 010 km
2.I ti sm o s t l yu r b a -
nized and is home to over 9.6 million people, over a
fifth of the national population [23]. The East and West
Rand regions are dominated by mining (Figure 1), while
the Vaal Triangle contains mainly manufacturing sectors
with a mix of agriculture, heavy and petrochemical
industries. Tshwane contains light industrial and resi-
dential areas, while Soweto is largely residential with
residents working mainly in Central Johannesburg and
the West Rand. Information on age, education level,
parity and gravidity of subjects was collected as part of
the original study. Geographic information on river
catchments in the areas was deduced from the location
of the different clinics. Ethics approval was granted by
the University of the Witwatersrand Research Ethics
Committee (Medical).
Laboratory Analysis
Laboratory diagnosis of HIV and syphilis was done by
the National Health Laboratory Services (NHLS), South
Africa. HIV antibodies were determined using an Abbot
Axysm System for HIV-1/HIV-2 ELISA assays (Abbott
Laboratories, Diagnostics Division, Abbott Park, Illinois)
and syphilis antibodies were determined using a non-
treponemal carbon antigen test. Leftover sera were
stored at -20°C before being shipped to the Viral Oncol-
ogy Section, AIDS and Cancer Virus Program, Science
Applications International Corporation (SAIC), National
Cancer Institute (NCI), Maryland, for determination of
antibodies to lytic K8.1 and latent open reading frame
(Orf) 73 KSHV antigens. In-house assays for detection
of antibodies to lytic K8.1 and latent Orf73 KSHV anti-
gens were used as detailed previously [12,23]. Seroposi-
tivity to KSHV was further defined when subjects tested
seropositive to either lytic KSHV K8.1 or latent KSHV
Orf73 antibodies. Available information on age, educa-
tion level, parity, gravidity, laboratory HIV and syphilis
results was anonymously linked to the KSHV data using
unique participant identification numbers.
Statistical Analysis
Descriptive statistical analysis and measures of effect
were done using SAS 9.1 (SAS Institute Inc, Cary, NC,
USA.). The Kappa coefficient () was calculated to
determine concordance between antibodies against the
lytic K8.1 and latent Orf73 antigens. Logarithmic trans-
formation of the antibody titres (expressed as optical
densities) for lytic K8.1 and latent Orf73 allowed for the
use of standard parametric statistical methods and
r e s u l t sa r ee x p r e s s e da st h eg e o m e t r i cm e a n( μg) and
standard deviation range (sg). Comparisons of means
were done using Bonferroni adjusted student t-test
b e t w e e ng r o u p so rA n a l y s i so fV a r i a n c e( A N O V A )
amongst multiple groups. Trends were measured using
the Cochran-Armitage Trend Test. We calculated preva-
lence odds ratios (PORs) and 95% Wald confidence
intervals (CIs) for KSHV seropositivity using logistic
regression. In a multivariate model PORs were adjusted
for age group (≤ 20, 21-25 26-30, ≥ 31), education level
in years (< 2 years, 2-5 years, 6-12 years and >12 years
(post matriculation/secondary school) of formal educa-
tion), municipal region (East Rand, Soweto, Pretoria,
Vaal Triangle and West Rand), syphilis seropositivity.
Chi-square (c) tests for binary measures, trend and
homogeneity were calculated and two-sided p-values
were used to measure the significance of the associa-
tions before and after adjustment for other covariates.
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Page 2 of 8Figure 1 Map of Gauteng province showing the locations of the ante-natal clinics. Locations of ante-natal clinics from which study
participants were recruited are shown according to the embedded legend. Altitude, water features and municipal boundaries are also shown
according to the embedded legend.
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The mean (± SD) age of all 1740 pregnant women
included in the study was 26.0 (± 6.2) years. Age was
similar amongst the following four municipal regions:
Ekurhuleni (26.5 (± 6.3)), Tshwane (25.8 (± 6.1)), West
Rand (26.4 (± 6.1)) and Emfuleni (25.9 (± 6.3)) (Table 1).
However, pregnant women attending clinics in Soweto
(24.9 (± 5.8)), were significantly younger than those from
the West Rand and Ekurhuleni municipalities (p = 0.043).
Lytic and latent KSHV Serology
O n et h i r d( 5 6 8 )o fa l lt h es u b j e c t sw e r es e r o p o s i t i v et o
lytic K8.1 antibodies and another overlapping third
(568) were seropositive to latent Orf73 antibodies
(Table 1). Overall, 776 (44.6%) subjects had antibodies
to either lytic K8.1 only (208), latent Orf73 only (208)
or both (360) and were considered to be KSHV sero-
positive. There was moderate concordance in seroposi-
tivity between the two (K8.1 and Orf73) assays ( =
0.46 95% CI: 0.41 - 0.50) consistent with previous stu-
dies[12,24].
The geometric mean (μg) of optical density for lytic
K8.1 was 0.77((sg 0.31 - 1.38). The mean lytic K8.1 anti-
body level, expressed as optical densities, were signifi-
cantly heterogeneous between municipal regions (P4df =
0.0069) and education levels (P4df = 0.0019)( T a b l e1 ) .
W o m e ni nT s h w a n ea n dS o w e t oh a dl o w e rl y t i cK 8 . 1
optical densities than those from the West Rand (μg
(sg):0.71(0.32 - 1.21) and 0.71(0.27 - 1.29), vs. 0.84(0.37 -
1.49), respectively (P4df = 0.0069)]. The μg (sg)f o rl a t e n t
orf73 was 0.40 (0.11 - 0.76) and did not differ signifi-
cantly between regions (P4df = 0.0675) or education levels
(P3df = 0.0874). HIV positive women had significantly
higher lytic and latent KSHV antibody levels than HIV
negative women (μg (sg): 1.0(0.50 - 1.69) vs. 0.70(0.28 -
1.27), (P1df <0 . 0 0 0 1 ) and 0.54(0.21 - 0.98), vs. 0.36(0.09 -
0.68), respectively) (P1df < 0.0001) (Table 1).
Risk Factors for KSHV
Age, Education and selected characteristics
Seropositivity to KSHV in these women in their reproduc-
tive years was not associated with age (Ptrend =0 . 5 9 8 8 )
Table 1 Lytic and latent KSHV antibody levels and Odds Ratios (OR’s) for seropositivity by municipal region, HIV and
syphilis status and education
Lytic K8.1 Latent Orf 73
Total
(n)
Age Mean
(± SD)
Total Positive (n)
(% Positive)
Antibody level μg
(SD range)
Adjusted OR
(95%CI)
Total
Positive
(n)
Antibody level μg
(SD range)*
Adjusted OR
(95%CI)
All Subjects 1740 26.0(6.2) 568(32.6) 0.77(0.31 -1.38) - 568(32.6) 0.40(0.11-0.76) -
Municipality
Region
Soweto 293 24.9(5.8)
ab 76(25.9) 0.71(0.27-1.29)
b 1 79(27.0) 0.37(0.09-0.73) 1
Ekurhuleni 567 26.5(6.3)
a 204(36.0) 0.79(0.30 - 1.46) 1.7(1.2 - 2.3)* 195(34.4) 0.40(0.11-0.77) 1.5(1.0 - 2.1)
Emfuleni 330 25.9(6.3) 107(32.4) 0.75(0.32-1.32) 1.5(1.0 - 2.1)* 118(35.8) 0.40(0.13-0.74) 1.7(1.2 - 2.4)*
Tshwane 207 25.8(6.1) 53(25.6) 0.71(0.32 -1.21)
a 1.1(0.7 - 1.7) 52(25.1) 0.36(0.10-0.68) 1.0(0.7 - 1.6)
West Rand 343 26.4 (6.1)
b 128(37.3) 0.84(0.37-1.49)
ab 1.6(1.1 - 2.3)* 124(36.2) 0.43(0.13-0.82) 1.5(1.0 - 2.2) *
P4df 0.0063 0.0069 0.0233 0.0675 0.0185
Education
Level
< 2 years 117 28.5 (7.9)
a 46(39.3) 0.90(1.67-0.35)
a 1 47(40.2) 0.45(0.12-0.90) 1
2 - 5 years 513 26.5 (6.8)
b 193(37.6) 0.82(0.32-1.48)
b 0.8 (0.5 - 1.2) 176(34.3) 0.40(0.11-0.85) 0.6(0.4 - 1.0)
6 - 12 years 119 26.4 (5.6) 35(29.4) 0.75(0.30-1.36) 0.4(0.3 - 0.8)* 37(31.1) 0.42(0.14-0.80) 0.5(0.3 - 0.9) *
Post Matric 959 25.4 (5.5)
ab 286(29.8) 0.73(0.31-1.30)
ab 0.6(0.4 - 0.8)* 300(31.3) 0.42(0.11-0.72) 0.6(0.4 - 0.9) *
P3df 0.042 0.0019 0.002 0.0874 0.0426
HIV
Infection
Negative 1338 26.2 (6.4) 345(25.8) 0.70(0.28-1.27) 1 341(25.5) 0.36(0.09-0.68) 1
Positive 402 25.3 (5.4) 223(55.5) 1.00(0.50-1.69) 3.7(2.9 - 4.7) * 227(56.5) 0.54(0.21-0.98) 3.8(3.0 - 4.8) *
P1df 0.011 < 0.0001 < 0.0001 < 0.0001 < 0.0001
Syphilis
Infection
Negative 1442 25.9 (6.2) 461(32.0) 0.77(0.31-1.38) 1 454(31.5) 0.39(0.10-0.75) 1
Positive 298 26.4 (5.8) 107(35.9) 0.79(0.34-1.38) 1.0 (0.7 - 1.3) 114(38.3) 0.43(0.15-0.81) 1.2 (0.9 - 1.6)
P1df 0.24 0.55 0.8924 0.087 0.2395
#μg(SD range) geometric mean and standard deviation range. Means with the same letter are significantly different (p, 0.05). * Statistically significant Odds Ratios.
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against HIV infection, this relationship was not seen in the
adjusted model. An inverse trend for KSHV was noted
with higher education levels (Ptrend =0 . 0 0 1 5 ) being protec-
tive against KSHV but not HIV infection. More than half
(53.0%) of the 117 women with no formal education (< 2
years) were seropositive to KSHV decreasing to 41.7% in
the 959 women with the highest high school matriculation
certificate (P3df = 0.008). The number of pregnancies and
live births had no effect on KSHV seropositivity. (Table 2).
KSHV, HIV and Syphilis serology
The overall seroprevalence of HIV and syphilis, in preg-
nant women across all the clinics was 23.1% and 17.1%,
respectively. Overall, 34.6% of all the women had either
HIV or syphilis but only 6% were infected with both.
Seropositivity to KSHV was 69.7% in HIV infected
women and 37.1% in uninfected women (p < 0.0001)
(Table 2). Pregnant women with syphilis also had higher
KSHV seroprevalences than those without (51.7% vs
43.1% respectively; p = 0.0028). The prevalence of HIV
and syphilis were 12.7% and 14.9% in pregnant women
without KSHV, and 36.1 and 19.9% in those with posi-
tive KSHV serology. The risk for KSHV was 4.1 fold
higher in those with HIV infection (4.1 95% CI: 3.1 -
5.2). However, KSHV was not associated with syphilis
(AOR 1.2 95% CI: 0.9 - 1.6) (Table 2). KSHV antibody
levels were higher in women with HIV but not in
women with syphilis (Table 1)
Geographic factors and KSHV serology
Seropositivity to KSHV was significantly different
amongst the municipal regions, ranging from 35.4% in
Tshwane to 49.0% in the West Rand (P4df =0 . 0 0 1 5 )
(Table 2). Risks of KSHV infection was higher in all
pregnant women attending clinics in Ekurhuleni and
Emfuleni and the West Rand regions, compared to
women attending clinics in Soweto (AOR 1.8 95% CI:
1.3 - 2.4; 1.8 95% CI: 1.1 - 2.6; and 1.7 95% CI: 1.1 -
2.5) (Table 2). While the risk for KSHV was similar
between Soweto and Tshwane, women in the Tshwane
region seem to be at a low risk for HIV infection com-
pared to those from Soweto (AOR 0.5 95%CI: 0.3 - 0.8)
(Table 2).
To further explore this geographic variation in KSHV
serology within this region, we looked at the river catch-
ments within the different regions. It was clear that
there were two main river catchment systems draining
south and north (Figure 1). KSHV seroprevalence was
higher in the areas with the southern river drainage
(45.6%) than those to the north (39.0%), however this
difference was not significant (p1df = 0.4, Table 2).
Discussion
Although HIV prevalence in South African women
attending public sector antenatal clinics is well
described [21], little is known about their KSHV sta-
tus. In the sub-Saharan African setting it is now
apparent that KSHV is an endemic infection affecting
both children and adults [10,12,25,26] and that HIV is
a significant co-factor in the pathogenesis of Kaposi’s
sarcoma [2,27,28]. In addition to studies suggesting
sexual transmission of KSHV [26] and among HIV
negative individuals [29], other studies on the epide-
miology of KSHV from endemic African and Mediter-
ranean countries have also established that the virus is
transmitted via non-sexual routes [9,10,12,30]. Our
findings provide further evidence for non-sexual hori-
zontal transmission of KSHV, likely via saliva. How-
ever, risk factors for KSHV infection, the exact mode
of KSHV transmission and other epidemiological co-
factors that may promote KSHV infection need further
elucidation.
In this study, KSHV seroprevalence in pregnant
women attending antenatal clinics in the Gauteng pro-
vince of South Africa was very high (45%) and nearly
double that of HIV infection (23%). This further con-
firms that KSHV infection is very common in Southern
African women consistent with previous reports where
reported prevalence ranged from 30% - 46% [6,12,26].
HIV was strongly associated with increased risk for
KSHV seropositivity as well as the risk of having both
lytic and latent antibodies, as we have previously
reported in a study of mothers and children from
throughout South Africa [12]. However, we have also
previously demonstrated in a mining community (Carle-
t o n v i l l e )w i t hv e r yh i g hp r e v a l e n c eo fb o t hH I Va n d
KSHV, that KSHV was not associated with HIV infec-
tion nor was it associated with other sexually trans-
mitted infections [9]. The reasons for this discrepancy is
unclear but may relate to the very high HIV prevalence
in the Carletonville study population[9]. None of these
studies found any association between KSHV infection
and other STD including syphilis. In this study HIV
positive subjects had significantly higher KSHV antibody
levels than their HIV negative counterparts, an associa-
tion not noted for syphilis. Higher antibody levels in
HIV positive subjects may reflect poor immune control
of KSHV resulting in more frequent reactivation.
The lack of association between KSHV and age
noted in this study may be attributed to the narrow
age range studied (mean (± SD) 25.9 (6.2)). In this
study, pregnant women with a higher level of educa-
tion had lower rates of KSHV infection. The associa-
tion between KSHV and increasing education has been
shown in other studies [29]. Education is often
reported to be a surrogate marker of socio-economic
status. implying that those with lower socio-economic
status are at a higher risk for KSHV infection, consis-
tent with previous reports [18,29].
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in Gauteng province of South Africa.
KSHV Seropositivity HIV Seropositivity
Total
(n)
Prevalence
Total n(%)
Unadjusted OR
#
(95%CI)
Adjusted OR
(95%CI)
Prevalence
Total n(%)
Unadjusted OR
(95%CI)
Adjusted OR
#
(95%CI)
All Subjects 1740 776
(44.6%)
-- 402(23.1%) - -
Age Group
≤ 20 362 154 (42.4) 1 1 87(24.0%) 1 1
21 - 25 533 246 (46.2) 1.2 (0.9 - 1.5) 1.2 (0.9 - 1.7) 136(25.5%) 1.1 (0.8 - 1.5) 1.1 (0.7 - 1.5)
26 - 30 438 192 (43.8) 1.1 (0.8 - 1.4) 1.1 (0.8 - 1.5) 108(24.7%) 1.0 (0.7 - 1.5) 1.0 (0.7 - 1.5)
≥ 31 407 184 (45.2) 1.1 (0.8 - 1.5) 1.2 (0.9 - 1.6) 71(17.4%) 0.7 (0.4 - 0.9)* 0.7 (0.5 - 1.0)*
P3df 0.6240 0.4830 0.0286 0.0373
Municipality
Region
Soweto 293 105(35.4) 1 1 72(24.6%) 1 1
Ekurhuleni 567 274 (48.3) 1.6 (1.3 - 2.2)* 1.8 (1.3 - 2.4) * 147(25.9%) 1.0 (0.7 - 1.5) 1.1 (0.7 - 1.6)
Emfuleni 330 152 (46.1) 1.5 (1.1 - 2.1) * 1.8 (1.1 - 2.6) * 63(19.1%) 0.8 (0.5 - 1.1) 0.7 (0.5 - 1.1)
Tshwane 207 77 (37.2) 1.1 (0.7 - 1.5) 1.3 (0.5 - 1.9) 29(14.0%) 0.5 (0.3 - 0.8)* 0.5 (0.3 - 0.8)*
West Rand 343 168 (49.0) 1.7 (1.2 - 2.4) * 1.7 (1.1 - 2.5) * 91(22.6%) 1.1 (0.8 - 1.6) 1.1 (0.7 - 1.7)
P4df 0.0015 0.0095 0.0017 0.0013
Education Level
< 2 years 117 62 (53.0) 1 1 17(14.5%) 1 1
2- 5 years 513 253 (49.3) 0.9 (0.6 - 1.3) 0.7 (0.5 - 1.1) 119(23.2%) 1.3 (0.8 - 2.1) 1.4 (0.8 - 2.6)
6 - 12 years 119 51 (42.9) 0.7 (0.4 - 1.1) 0.5 (0.3 - 0.8)* 31(26.0%) 1.6 (0.8 - 3.1) 1.4 (0.7 - 2.8)
Post Matric 959 400 (41.7) 0.6(0.4 - 0.9)* 0.5 (0.4 - 0.8)* 228(23.8%) 1.4 (0.9 - 2.1) 1.6 (0.9 - 2.8)
P3df 0.0080 0.0034 0.1645 0.3437
Gravidity Group
1 631 269 (42.6) 1 - 144(22.8%) 1 -
2 481 223 (46.4) 1.2 (0.9 - 1.5) - 129(26.8%) 1.2 (1.0 - 1.6)* -
≥2 532 246 (46.2) 1.2 (0.9 - 1.5) - 106(28.0%) 0.8 (0.6 - 1.1) -
P2df 0.2863 0.0284
Parity group
0 649 279 (43.0) 1 - 149(23.0%) 1 -
1 487 223(45.8) 1.1 (0.9 - 1.5) - 129(26.5%) 1.2 (0.9 - 1.6) -
> 2 506 235(46.4) 1.2 (0.9 - 1.5) - 56(20.1%) 0.9 (0.6 - 1.1) -
P2df 0.3594 0.0263
River Catchment
North 279 109 (39.1) 1 - 48(17.2%) 1 -
South 1461 667 (45.6) 0.8 (0.4 - 1.5) - 354(24.2%) 0.6 (0.4 - 0.9)* -
P1df 0.4312 0.0075
Syphilis
Non-reactive 1440 621 (43.1) 1 1 303(21.0%) 1 1
Reactive 298 154 (51.7) 1.4 (1.1 - 1.8)* 1.2 (0.9 - 1.6) 97(32.5%) 1.8 (1.4 - 2.4)* 1.9 (1.4 - 2.5)*
P1df 0.0028 0.1168 < 0.0001 < 0.0001
HIV infection
Negative 1338 496 (37.1) 1 1 - -
Positive 402 280 (69.7) 3.9 (3.1 - 5.0)* 4.1 (3.1 - 5.2)* - -
P1df < 0.0001 < 0.0001
# Adjusted for age group, education levels, municipal region, syphilis seropositivity and/or HIV status. *Statistically significant Odds Ratios.
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KSHV between the regions within the Gauteng province
of South Africa which remained after adjustment for
several factors including age, HIV, syphilis status and
e d u c a t i o n( T a b l e2 ) .T h i si st h ef i r s ts t u d yi ns u b -
Saharan Africa to demonstrate such geographical varia-
tion within a province. In the apartheid era, most South
African townships were segregated according to ethnic
and, therefore, geographic origin of the residents. It fol-
lows that some of this variation may be explained by
differences in cultural practices.
Living in close proximity to rivers and streams has
previously been associated with increased risk for KSHV
[17]. We did not have information on place of residence
for the women in our study, only the clinic that they
attended. Therefore, we were unable to test this hypoth-
esis. Further studies are warranted to clarify the nature
of the geographical variation in KSHV prevalence
observed in this study.
Women attending routine ante-natal clinics are fre-
quently used in surveys of HIV prevalence in South
Africa and other African countries. Assessing KSHV
prevalence in this population therefore allows for valid
comparisons between this study and future studies in
other parts of South Africa or other African countries.
This study adds to findings in South Africa and other
African countries [31] which suggest a lack of evidence
for sexual transmission of KSHV in heterosexual African
populations. Cross-sectional studies of KSHV and other
serology, while providing important information on risk
factors for KSHV transmission, have limitations. A long-
itudinal study of KSHV transmission in South Africa is
needed as well as studies aiming to identify geographi-
cal, cultural and/or lifestyle and environmental factors
that may predispose people to KSHV infection.
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